[Skip to Content]
Access to paid content on this site is currently suspended due to excessive activity being detected from your IP address 54.204.139.136. Please contact the publisher to request reinstatement.
[Skip to Content Landing]
Citations 0
Letters
November 3, 2010

2010 Guidelines for Antiretroviral Treatment of HIV From the International AIDS Society–USA Panel

JAMA. 2010;304(17):1897-1898. doi:10.1001/jama.2010.1561

To the Editor: In their 2010 guidelines, the International AIDS Society–USA panel reinforced the recommendation to initiate combination antiretroviral treatment (cART) in individuals infected with human immunodeficiency virus (HIV) with rapid CD4 cell count decline of greater than 100/μL per year (level of evidence rating AIIa).1,2 In so doing, the panel ignored recent evidence from the large CASCADE collaboration of a lack of association between the pretreatment CD4 cell slope and the hazards of AIDS and death in ART-naive patients.3

First Page Preview View Large
First page PDF preview
First page PDF preview
×